Caplin Point Laboratories’ subsidiary -- Caplin Steriles has received approval from Brazil’s National Health Surveillance Agency ANVISA (Agencia Nacional de Vigilancia Sanitaria) for its sterile injectable manufacturing site near Chennai, Tamilnadu. The approval grants access to the company to register and market its products in Brazil, the largest Pharmaceutical market in Latin America.
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
